Abiopharma

🔍 Rosati Fabio (Executive)

Company: Xometry, Inc. (XMTR)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 7,400 shares of Class A Common Stock at $91.298 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: false | shares_owned_after: 94,267.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 200 shares of Class A Common Stock at $91.935 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: false | shares_owned_after: 94,067.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 500 shares of Class A Common Stock at $93.425 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: false | shares_owned_after: 93,567.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,900 shares of Class A Common Stock at $89.7182 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: false | shares_owned_after: 91,667.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.82 to $91.79, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.86 to $92.01, inclusive.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.41 to $93.49, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.29 to $90.06, inclusive.